Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,163
Award facts
- Contract value 100% obligated
- $13,163.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,163.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Dupixent 300 mg/2 ml pens (2 ml vials). This non-set-aside competitive award is scheduled for completion by January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent is a biologic medication used to treat conditions including atopic dermatitis, moderate-to-severe asthma, and chronic rhinosinusitis with nasal polyps. This delivery order exemplifies the routine pharmaceutical procurement operations under the DLA's medical supply chain, through which AmerisourceBergen and Cencora supply specialty medications, brand-name drugs, and critical care materials to military treatment facilities and federal healthcare systems. The award reflects the contractor's established capability to meet federal medical procurement requirements through open competition and its role as a critical vendor for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FMK0A?
SPE2DR26FMK0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FMK0A worth?
The government has obligated $13,163 on SPE2DR26FMK0A.
Is contract SPE2DR26FMK0A an order under another contract?
Yes. SPE2DR26FMK0A is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK0A competed?
The extent of competition for SPE2DR26FMK0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award